Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Wiedenmann

Showing results (11-20 of 252) with videos related to

Pageof 26
Sort By:
Cancer Treatment Reviews|October 31, 2003
Adding interferon-alpha to octreotide slows tumour progression compared with octreotide alone but evidence is lacking for improved survival in people with disseminated midgut carcinoid tumoursUlrich Frank Pape, Bertram Wiedenmann
Neuroendocrinology|October 13, 2004
From basic to clinical research in gastroenteropancreatic neuroendocrine tumor disease -- the clinician-scientist perspectiveBertram Wiedenmann, Ulrich-Frank Pape
Gut|July 14, 2009
Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseasesMathias Z Strowski, Bertram Wiedenmann
Neuroendocrinology|September 7, 2011
From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumorsBertram Wiedenmann, Marianne Pavel, Beata Kos-Kudla
Neuroendocrinology|January 21, 2012
ENETS 2011 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: an updateRamon Salazar, Bertram Wiedenmann, Guido Rindi, et al.
Frontiers in Endocrinology|April 24, 2018
Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell LinesSamantha Exner, Vikas Prasad, Bertram Wiedenmann, et al.
Neuroendocrinology|August 29, 2009
ENETS Consensus Guidelines for the Standard of Care in Neuroendocrine TumorsUrsula Plöckinger, Bertram Wiedenmann, Wouter W de Herder
Neuroendocrinology|September 25, 2009
The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumorsUrsula Ploeckinger, Guenter Kloeppel, Bertram Wiedenmann, et al.
Inflammatory Bowel Diseases|October 12, 2004
Successful therapy of refractory pyoderma gangrenosum and periorbital phlegmona with tacrolimus (FK506) in ulcerative colitisDaniel C Baumgart, Bertram Wiedenmann, Axel U Dignass
Neuroendocrinology|April 22, 2010
ENETS consensus guidelines for the management of patients with rare metastases from digestive neuroendocrine tumors: rationale and working framework. IntroductionDermot O'Toole, Guido Rindi, Ursula Plöckinger, et al.
Pageof 26

Showing results (11-20 of 252) with videos related to

Sort By:
Pageof 26
Cancer Treatment Reviews|October 31, 2003
Adding interferon-alpha to octreotide slows tumour progression compared with octreotide alone but evidence is lacking for improved survival in people with disseminated midgut carcinoid tumoursUlrich Frank Pape, Bertram Wiedenmann
Neuroendocrinology|October 13, 2004
From basic to clinical research in gastroenteropancreatic neuroendocrine tumor disease -- the clinician-scientist perspectiveBertram Wiedenmann, Ulrich-Frank Pape
Gut|July 14, 2009
Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseasesMathias Z Strowski, Bertram Wiedenmann
Neuroendocrinology|September 7, 2011
From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumorsBertram Wiedenmann, Marianne Pavel, Beata Kos-Kudla
Neuroendocrinology|January 21, 2012
ENETS 2011 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: an updateRamon Salazar, Bertram Wiedenmann, Guido Rindi, et al.
Frontiers in Endocrinology|April 24, 2018
Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell LinesSamantha Exner, Vikas Prasad, Bertram Wiedenmann, et al.
Neuroendocrinology|August 29, 2009
ENETS Consensus Guidelines for the Standard of Care in Neuroendocrine TumorsUrsula Plöckinger, Bertram Wiedenmann, Wouter W de Herder
Neuroendocrinology|September 25, 2009
The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumorsUrsula Ploeckinger, Guenter Kloeppel, Bertram Wiedenmann, et al.
Inflammatory Bowel Diseases|October 12, 2004
Successful therapy of refractory pyoderma gangrenosum and periorbital phlegmona with tacrolimus (FK506) in ulcerative colitisDaniel C Baumgart, Bertram Wiedenmann, Axel U Dignass
Neuroendocrinology|April 22, 2010
ENETS consensus guidelines for the management of patients with rare metastases from digestive neuroendocrine tumors: rationale and working framework. IntroductionDermot O'Toole, Guido Rindi, Ursula Plöckinger, et al.
Pageof 26